236 results on '"Siddiqui, Bilal A."'
Search Results
2. Surgical Management and Considerations for Patients with Localized High-Risk Prostate Cancer
3. Correction to: Surgical Management and Considerations for Patients with Localized High-Risk Prostate Cancer
4. Structured segment rescaling with Gaussian processes for parameter efficient ConvNets
5. Characteristics and outcomes of cancer patients with pre-existing microscopic colitis after exposure to PD-1 and PD-L1 inhibitors
6. Immune checkpoint therapy—current perspectives and future directions
7. Impact of Selective Immunosuppressive Therapy on Subsequent Immune-Related Adverse Events After Immune Checkpoint Inhibitor-Induced Colitis Treatment
8. Development of a Strategic Initiative at MD Anderson Cancer Center to Improve Outcomes in Immune-Related Adverse Events
9. Monostotic Scapular Caffey Disease: A Case Report With MRI Correlate
10. Structured Segment Rescaling with Gaussian Processes for Parameter Efficient Convnets
11. Image-Guided Biopsy/Liquid Biopsy
12. Paraneoplastic Cerebellar Degeneration (PCD) associated with PCA-1 antibodies in established cancer patients
13. Distributed Nonlinear MPC of Multi-Agent Systems with Data Compression and Random Delays - Extended Version
14. Efficient ConvNet Optimization through Width Modification Guided with Gaussian Processes
15. Evaluation of the Aggressive-Variant Prostate Cancer Molecular Signature in Clinical Laboratory Improvement Amendments (CLIA) Environments
16. Clinical efficacy of lurbinectedin in metastatic neuroendocrine carcinomas of the genitourinary tract: Multi-institutional real-world experience.
17. Association of inherited steroidogenic genotype with body composition changes after androgen signaling inhibition (ASI) in men with biochemical recurrent (BCR), hormone-sensitive prostate cancer (HSPC).
18. Molecular pathways and cellular subsets associated with adverse clinical outcomes in overlapping immune-related myocarditis and myositis
19. A Framework for High Level Simulation and Optimization of Coarse-Grained Reconfigurable Architectures
20. Demographics and rates of surgical arthroscopy and postoperative rehabilitative preferences of arthroscopists from the Arthroscopy Association of North America (AANA)
21. Use of positron emission tomography for the diagnosis of immune-checkpoint inhibitor| myocarditis
22. Cancer Cell-Extrinsic Roles for the Androgen Receptor in Prostate Cancer
23. Body composition as a determinant of the therapeutic index with androgen signaling inhibition
24. Immune and pathologic responses in patients with localized prostate cancer who received daratumumab (anti-CD38) or edicotinib (CSF-1R inhibitor)
25. A phase II trial modifying metabolic syndrome and cardiovascular risk for patients with prostate cancer on ADT using a risk factor modification program and continuous Fitbit monitoring (ProTrio).
26. International multicenter study comparing COVID-19 in patients with cancer to patients without cancer: impact of risk factors and treatment modalities on survivorship
27. Fault Tolerant Flight Control Using Sliding Modes and Subspace Identification-Based Predictive Control
28. Impact of Selective Immunosuppressive Therapy on Subsequent Immune-Related Adverse Events After Immune Checkpoint Inhibitor-Induced Colitis Treatment.
29. Use of behavioural change taxonomies in systematic reviews and meta‐analyses regarding obesity management
30. Characteristics and outcomes of cancer patients with pre-existing microscopic colitis after exposure to PD-1 and PD-L1 inhibitors
31. 749 Use of positron emission tomography for the diagnosis of immune checkpoint inhibitor myocarditis
32. 1262 Elevated serum TNF-α is a candidate prognostic biomarker for immune checkpoint inhibitor myocarditis
33. Cancer Immunotherapy
34. S185 Characteristics and Outcomes of Cancer Patients With Pre-existing Microscopic Colitis After Exposure to Immune Checkpoint Inhibitors
35. UDDI-based Electronic Marketplaces
36. Web Services Business Strategies and Architectures
37. International Multicenter Study Comparing Cancer to Non-Cancer Patients with COVID-19: Impact of Risk Factors and Treatment Modalities on Survivorship
38. Characteristics and outcomes of cancer patients with pre-existing microscopic colitis after exposure to immune checkpoint inhibitors
39. Unraveling the clinicopathological features driving the emergence of ESR1 mutations in metastatic breast cancer
40. Use of taxonomies in systematic reviews regarding obesity management
41. Abstract CT211: A phase 1 dose-escalation and dose-expansion study to evaluate the safety, pharmacokinetics, and anti- tumor activity of ARX517 in subjects with advanced solid tumors resistant or refractory to standard therapies (APEX-01 trial, NCT04662580)
42. Anti-PD-L1 plus enzalutamide does not improve overall survival in prostate cancer
43. Salvage Therapy with High-Dose Chemotherapy and Peripheral Blood Stem Cell Transplant in Patients with Primary Mediastinal Nonseminomatous Germ Cell Tumors
44. Use of behavioural change taxonomies in systematic reviews and meta‐analyses regarding obesity management.
45. UPFRONT IMMUNOMODULATORY TREATMENT OF IMMUNE CHECKPOINT INHIBITOR MYOCARDITIS
46. A composite T cell biomarker in pre-treatment blood samples correlates with detection of immune-related adverse events
47. Third analysis of a randomized trial of finite abiraterone acetate (AA) plus LHRH agonist (LHRHa) versus LHRHa in biochemically recurrent, non-metastatic hormone-naïve prostate cancer (M0HNPC).
48. Analysis of Systematic Reviews in Clinical Practice Guidelines for Head and Neck Cancer
49. 352 Target modulation within the tumor microenvironment (TME) by daratumumab (anti-CD38) but not edicotinib (CSF-1R inhibitor) in men with high-risk localized prostate cancer
50. 22. International Multicenter Study Comparing Cancer to Non-Cancer Patients with COVID-19: Impact of Risk Factors and Treatment Modalities on Outcome
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.